Meanwhile, Semaglutide GLP-1 (Ozempic, Wegovy) has shown promising results in terms of weight loss, despite its primary use for treating type 2 diabetes
According to FDA prescribing information, alopecia was reported in 3.5% of patients taking Wegovy (semaglutide 2.4 mg) compared to 1.0% on placebo
Those sources, who requested anonymity due to fear of reprisals, said it drew the interest of top health officials, suggesting the person receiving this drug was well connected
On non-treatment days within the cycle, GHK-Cu's daily topical (if you use one) layers under retinol at night without conflict
As of 2025, retatrutide has not received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for routine clinical use in the UK